Home News Albemarle Corporation (NYSE: ALB) Announces Retirement of Matt Juneau, Executive Vice President,...

Albemarle Corporation (NYSE: ALB) Announces Retirement of Matt Juneau, Executive Vice President, Corporate Strategy& Shareholder Relations; Names Eric W. Norris As Successor

1356
0

Albemarle Corporation (NYSE: ALB), a manager in the world specialty chemicals industry, confirmed just now that Matt Juneau, executive vice president, Corporate Strategy & Shareholder Relations, is resigning from the organization in March 2018 and that it has named Eric W. Norris as Albemarle’s chief strategy officer, effective right away.As chief strategy officer, Norris will be accountable for both Corporate Strategy and Shareholder Relationships.

Juneau will be resigning after more than 35 years with Albemarle Corporation and its predecessor, Ethyl Corporation. Throughout his career at Albemarle, Juneau has aided in positions of increasing accountability, counting senior VP, president, Performance Chemicals, vice president, Polymer Solutions and vice president, Global Sales, and Services. “On behalf of the Board of Directors and the leadership team, we thank Matt for his many years of devoted service to Albemarle,” said Albemarle Chairman, President, and Chief Executive Officer Luke Kissam. “We desire Matt the best in his retirement.”

Norris links Albemarle as a seasoned executive with over 20 years of diverse practice in the corporate development and business leadership. Before connecting Albemarle, he assisted in several roles with FMC Corporation over a 15-year period. Most recently, he contributed as president, FMC Health, and Nutrition, where he was accountable for leading a segment with over $750 million of income, 13 stand-alone plants and 12 globally dispersed R&D centers and more than 1,000 workers. Before taking on that role, Norris assisted for five years in FMC’s Lithium segment, first as global commercial director before moving up to vice president and global business director. Other roles at FMC comprised director, Corporate Development, and in its BioPolymer segment, director, Healthcare Ventures.

“We are pleased to welcome Eric to Albemarle,” stated Kissam. “We look forward to the leadership and contributions his wealth of skills will bring to us. I am sure that his business experiences and insights, joint with his leadership skills, will allow him to make notable contributions to Albemarle’s future achievement.”